Test Update

Cessation of Myoglobin

Canterbury Health Laboratories wishes to advise that Myoglobin (both urine and plasma/serum) will no longer be available from 31st December 2020. Myoglobin was previously estimated as an early marker of muscle damage. However, it has largely been replaced by the measurement of Creatine Kinase (CK). Urine myoglobin has also been replaced with the estimation of […]

Transition of Blood Borne Virus Testing

Canterbury Health are continuing their phased introduction of their new Molecular Platform with the transition of viral load testing of blood borne viruses. Read more here

Change to sample requirements for Serum 17-Hydroxyprogesterone and Androstenedione

Due to a recent change in methodology the sample requirements for 17-Hydroxyprogesterone and Androstenedione have changed. A red top tube is now required. Read more here

Cessation of Free PSA Testing

Canterbury Health Laboratories wishes to advise that Free PSA (fPSA) will no longer be available from Friday 30 October 2020. Read more here

Phased Introduction of a new Molecular Testing Platform

Canterbury Health Laboratories wishes to advise that, as they continue their phased introduction of the new Molecular Platform, the Alinity M, there will be changes over the coming weeks to viral load testing of blood borne viruses. Read more here

Level 2 Testing Restrictions

Restriction in asymptomatic Chlamydia and Gonorrhoea testing. Laboratories are re-directing resources to COVID-19 testing, other tests that require molecular reagents are being restricted. From Thursday 20 August all Chlamydia and Gonorrhoea tests will be restricted. Restrictions to Screening for GDM Recommendations from New Zealand Society for the Study of Diabetes

Change to Anti-dsDNA antibody testing requirements

Anti-dsDNA antibody samples received by the laboratories must now be accompanied by relevant clinical details, and prior testing history, to be processed. Background Antibodies to native or double-stranded DNA are found primarily in systemic lupus erythematosis (SLE). They are thought to be involved in the pathogenesis of the most severe forms of SLE when deposited […]

Discontinuation of Heliobacter pylori serology

Canterbury SCL would like to inform referrers that Helicobacter pylori serology will no longer be routinely available from Friday 31 July 2020. H. pylori serology is a test that measures IgG antibodies specific to H. pylori in serum as evidence of infection at some time. This test is unable to determine if antibodies are present […]

Change to requirements for ESR testing

As of 13 July 2020 all ESR samples received by the laboratories must be accompanied by relevant clinical details in order to be processed. ESRs without relevant clinical details, as per table below, will not be processed. Systemic lupus erythematosus (SLE) in childrenJuvenile idiopathic arthritisKawasaki diseaseRheumatic feverSuspected prosthetic joint inflammationPolymyalgia RheumaticaTemporal (giant cell) arteritis Requesting […]

Aptima Multitest Kits

Our supplier of the Aptima Multitest collection kits have informed us these are on global allocation and this product is on backorder. We are expecting kits to arrive in around 2- 3 weeks time. Please stock for your requirements only and do not overstock. If you have stock of any short-dated collection kits close to expiry, […]